Moderna has outperformed many of its peers and the broader market YTD, but Wall Street analysts are cautiously optimistic about the stock's prospects.
Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.
VanEck today announced the launch of the VanEck Robotics ETF (IBOT) , a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics...
Sector ETF report for BBH
Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.
The latest earnings from some of the big biotech players came in at mixed this reporting season.
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Sector ETF report for BBH
Sector ETF report for BBH